Carolyn brings over 20 years of experience in management, commercial and business development across the Biotech, Vaccines, Pharma, Finance and University sectors.
She is currently Chief Business Officer of OxStem, a disruptive regenerative medicine drug discovery company. She was previously Deputy Head of Technology Transfer at Oxford University Innovation where she transacted some of the company’s largest licensing deals and led or mentored the formation of 16 spin-out companies that collectively raised £52million in seed financing. Carolyn has also held senior business development roles in Novartis Vaccines and Chiron Vaccines.
Her earlier career included time as a biotech analyst and then in Corporate Finance at Ernst & Young. She has a PhD in Immunology from Trinity College Dublin and an MBA from Warwick Business School.